KUALA LUMPUR: Initial delays in the procurement of vaccines under the National Covid-19 Immunisation Programme were caused by unnecessary red tape by the National Pharmaceutical Regulatory Agency (NPRA), claims Datuk Seri Saifuddin Nasution Ismail (PH-Kulim Bandar Bharu).
Saifuddin said Malaysia missed out on a golden opportunity to procure vaccines last year, while pointing out first-world countries such as Singapore and the United States had approved the Pfizer-BioNTech vaccine as early as last December.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
